The past decade in Parkinson's disease (PD) research has been punctuated by numerous advances in understanding genetic factors that contribute to the disease. Common to most of the genetic models of Parkinsonian neurodegeneration are pathologic mechanisms of mitochondrial dysfunction, secretory vesicle dysfunction and oxidative stress that likely trigger common cell death mechanisms. Whereas presynaptic function is implicated in the function/dysfunction of α-synuclein, the first gene shown to contribute to PD, synaptic function has not comprised a major focus in most other genetic models. However, recent advances in understanding the impact of mutations in parkin and LRRK2 have also yielded insights into synaptic dysfunction as a possible early pathogenic mechanism. Autophagy is a common neuronal response in each of these genetic models of PD, participating in the clearance of protein aggregates and injured mitochondria. However, the potential consequences of autophagy upregulation on synaptic structure and function remain unknown. In this review, we discuss the evidence that supports a role for synaptic dysfunction in the neurodegenerative cascade in PD, and highlight unresolved questions concerning a potential role for autophagy in either pathological or compensatory synaptic remodeling. This article is part of a Special Issue entitled "Autophagy and protein degradation in neurological diseases."
Introduction
Parkinson's disease (PD) is a progressive, debilitating neurodegenerative disease characterized clinically by deterioration of motor capacities and, in many patients, dementia. The hallmark diagnostic pathology of PD is comprised of neuronal cell death and Lewy bodies/ neurites in the substantia nigra, several additional brainstem nuclei and areas of the cerebral cortex. Although our understanding of the multifactorial etiology of PD is far from complete, numerous monogenic determinants of the disease identified in kindreds with familial PD, together with a growing number of genetic risk factors identified in large cohorts of patients with sporadic PD, have provided opportunities to investigate the functions of proteins that likely play pivotal roles in the neurodegenerative cascade (Lesage and Brice, 2009).
Protein aggregation, mitochondrial dysfunction, secretory pathway organelle dysfunction and oxidative stress represent common factors in various models of Parkinsonian neurodegeneration (Cookson and van der Brug, 2008). Synaptic dysfunction, implicated in numerous studies of the first known genetic determinant of PD, α-synuclein, is beginning to emerge as a factor in other genetic models of PD. In this review, we will discuss evidence that the PD gene products LRRK2, parkin and α-synuclein play roles in regulating synaptic (dys)function. We will also highlight emerging questions concerning possible roles for autophagy in the neuritic/synaptic compartment in LRRK2, parkin and α-synuclein 
